Cited by 27Extracellular vesicles in diseaseNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Nanotechnology-Inspired Extracellular Vesicles Theranostics for Diagnosis and Therapy of Central Nervous System Diseases

Tian, Tian, Qiao, Shuya, Tannous, Bakhos A.·2023·ACS Applied Materials & Interfaces

Abstract

Shuttling various bioactive substances across the blood-brain barrier (BBB) bidirectionally, extracellular vesicles (EVs) have been opening new frontiers for the diagnosis and therapy of central nervous system (CNS) diseases. However, clinical translation of EV-based theranostics remains challenging due to difficulties in effective EV engineering for superior imaging/therapeutic potential, ultrasensitive EV detection for small sample volume, as well as scale-up and standardized EV production. In the past decade, continuous advancement in nanotechnology provided extensive concepts and strategies for EV engineering and analysis, which inspired the application of EVs for CNS diseases. Here we will review the existing types of EV-nanomaterial hybrid systems with improved diagnostic and therapeutic efficacy for CNS diseases. A summary of recent progress in the incorporation of nanomaterials and nanostructures in EV production, separation, and analysis will also be provided. Moreover, the convergence between nanotechnology and microfluidics for integrated EV engineering and liquid biopsy of CNS diseases will be discussed.

Integrity signals

Registry

Crossref · 10.1021/acsami.2c07981

Cites

182 of 182 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Integration of EVs with nanotechnology has enormous potential to overcome the limitations encountered when utilizing either approach alone in theranostics for CNS diseases.

    “From this point of view, the integration of EVs with nanotechnology has enormous potential to overcome the limitations encountered when utilizing either approach alone in theranostics for CNS diseases [49–51].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tian, T., Qiao, S., & Tannous, B. A.
Affiliations
  • Harvard University (US)
  • Nanjing Medical University (CN)
Corresponding author
  • Tian, Tian
  • Tannous, Bakhos A.
Venue
ACS Applied Materials & Interfaces
Published
2022-08-05
Volume
15
Issue
1
Pages
182-199
ISSN
  • 1944-8244 (ISSN-L)
  • 1944-8252
OpenAlex
W4290012640
Cited by
27
References
182
Citations by year
2026: 6 · 2025: 11 · 2024: 4 · 2023: 4 · 2022: 2
FWCI
0.55
Type
journal article
Language
en
Open access
closed
Locations
  • ACS Applied Materials & Interfaces (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (P01CA069246)
  • National Institute of Neurological Disorders and Stroke (R21NS111922)
  • National Natural Science Foundation of China (81972364)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
extracellular vesicles, theranostics, central nervous system disorders, blood-brain barrier, nanomaterials, EV engineering, microfluidics, liquid biopsy, neuroimaging, neurotherapy
MeSH terms
Extracellular Vesicles, Central Nervous System Diseases, Humans, Nanotechnology, Nanostructures, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review